+351.0%
MRNA vs KRMN
+17.6%
+333.4%
-37.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | KRMN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.6% | +2.8% | +4.8% |
| 7D | -1.1% | -11.8% | +10.7% | +1.4% |
| 30D | +126.1% | -43.0% | +169.1% | +154.0% |
| 3M | +190.0% | -28.8% | +218.9% | +207.3% |
| 6M | +157.2% | -66.3% | +223.6% | +215.2% |
| YTD | +388.2% | -51.8% | +440.0% | +451.3% |
| 1Y | +467.0% | -44.7% | +511.7% | +522.7% |
| All | +351.0% | +17.6% | +333.4% | +334.4% |
Cumulative growth
Daily Returns
Daily percentage return beside KRMN.
Daily Out/Under-Performance
Portfolio return minus KRMN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × KRMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded KRMN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling